Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries

dc.contributor.advisorDel Portillo, Hernando A.
dc.contributor.authorMongui, Alvaro
dc.contributor.authorPérez-Llanos, Francy J.
dc.contributor.authorYamamoto, Marcio M.
dc.contributor.authorLozano, Marcela
dc.contributor.authorZambrano, Maria M.
dc.contributor.authorPortillo, Patricis Del
dc.contributor.authorFernández Becerra, María del Carmen
dc.contributor.authorRestrepo, Silvia
dc.contributor.authorJunca, Howard
dc.date.accessioned2016-02-04T13:03:18Z
dc.date.available2016-02-04T13:03:18Z
dc.date.issued2015-06-04
dc.date.updated2016-02-02T15:34:04Z
dc.description.abstractBACKGROUND: The chemical treatment of Plasmodium falciparum for human infections is losing efficacy each year due to the rise of resistance. One possible strategy to find novel anti-malarial drugs is to access the largest reservoir of genomic biodiversity source on earth present in metagenomes of environmental microbial communities. METHODS: A bioluminescent P. falciparum parasite was used to quickly detect shifts in viability of microcultures grown in 96-well plates. A synthetic gene encoding the Dermaseptin 4 peptide was designed and cloned under tight transcriptional control in a large metagenomic insert context (30 kb) to serve as proof-of-principle for the screening platform. RESULTS: Decrease in parasite viability consistently correlated with bioluminescence emitted from parasite microcultures, after their exposure to bacterial extracts containing a plasmid or fosmid engineered to encode the Dermaseptin 4 anti-malarial peptide. CONCLUSIONS: Here, a new technical platform to access the anti-malarial potential in microbial environmental metagenomes has been developed.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1475-2875
dc.identifier.pmid26040274
dc.identifier.urihttps://hdl.handle.net/2445/69246
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1186/s12936-015-0748-6
dc.relation.ispartofMalaria Journal, 2015, vol. 14, num. 233, p. 1-6
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/245226/EU//MAGICPAH
dc.relation.urihttp://dx.doi.org/10.1186/s12936-015-0748-6
dc.rightscc by (c) Mongui et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationGenòmica
dc.subject.classificationGenètica microbiana
dc.subject.classificationMalària
dc.subject.classificationPlasmodium falciparum
dc.subject.classificationResistència als medicaments
dc.subject.classificationEfecte dels medicaments sobre els microorganismes
dc.subject.otherGenomics
dc.subject.otherMicrobial genetics
dc.subject.otherMalaria
dc.subject.otherPlasmodium falciparum
dc.subject.otherDrug resistance
dc.subject.otherEffect of drugs on microorganisms
dc.titleDevelopment of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
mongui2015_1899.pdf
Mida:
665.29 KB
Format:
Adobe Portable Document Format